Salix Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Net Operating Cash Flow | 76.2 | 17.9 | 3.0 |
| Net Investing Cash Flow | (59.4) | (12.8) | 9.6 |
| Net Financing Cash Flow | 18.1 | 4.2 | 6.5 |
| Net Change in Cash | 34.8 | 9.3 | 19.1 |
| Depreciation & Amortization | 10.6 | 6.5 | 3.4 |
| Capital Expenditures | (2.4) | (1.7) | (2.4) |
| Cash Dividends Paid | -- | -- | -- |





